Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology
Reference100 articles.
1. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives;Pauwels;Nature,1990
2. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor;Merluzzi;Science,1990
3. 2-pyridinone derivatives: a new class of nonnucleoside, HIV-1-specific reverse transcriptase inhibitors;Saari;J Med Chem,1991
4. [2′,5′-Bis-O-(tert-butyldimethylsilyl)]- 3′-spiro-5′′-(4′′-amino-1′′,2′′-oxathiole-2′′,2′′-dioxide) (TSAO) derivatives of purine and pyrimidine nucleosides as potent and selective inhibitors of human immunodeficiency virus type 1;Balzarini;Antimicrob Agents Chemother,1992
5. Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication;Romero;Proc Natl Acad Sci USA,1991
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dual acting HIV inhibitors: integrated rational in silico design strategy;Medicinal Chemistry Research;2013-06-14
2. Arylazolylthioacetanilide. Part 8☆: Design, synthesis and biological evaluation of Novel 2-(2-(2,4-Dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides As Potent HIV-1 inhibitors;European Journal of Medicinal Chemistry;2011-10
3. Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs);Journal of Antimicrobial Chemotherapy;2009-11-10
4. Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patients;AIDS;2009-10-23
5. Pyrazole NNRTIs 1: Design and initial optimisation of a novel template;Bioorganic & Medicinal Chemistry Letters;2009-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3